(Q41312371)

29 September 2017

1 reference

title

Costimulation and autoimmunity (English)

1 reference

29 September 2017

Tivol EA

1

1 reference

29 September 2017

Schweitzer AN

series ordinal

2

1 reference

29 September 2017

Sharpe AH

series ordinal

3

1 reference

29 September 2017

language of work or name

1 reference

1 December 1996

1 reference

Current Opinion in Immunology

29 September 2017

1 reference

29 September 2017

8

1 reference

29 September 2017

822-830

1 reference

29 September 2017

6

1 reference

The B7 and CD28 receptor families

29 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

How B and T cells talk to each other

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

CD28/B7 system of T cell costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

CTLA-4 can function as a negative regulator of T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

CTLA4 mediates antigen-specific apoptosis of human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Lymphocyte activation: T-cell regulation by CTLA-4

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Evidence that induction of tolerance in vivo involves active signaling via a B7 ligand-dependent mechanism: CTLA4-Ig protects V beta 8+ T cells from tolerance induction by the superantigen staphylococcal enterotoxin B

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Role of Fas-mediated cell death in the regulation of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Enhancement of antitumor immunity by CTLA-4 blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

CTLA-4: a negative regulator of autoimmune disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

CTLA-4 ligation blocks CD28-dependent T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Of ITAMs and ITIMs: turning on and off the B cell antigen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Potential roles of the B7 and CD28 receptor families in autoimmunity and immune evasion

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Treatment of murine lupus with CTLA4Ig

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Elevated expression of CD80 (B7/BB1) and other accessory molecules on synovial fluid mononuclear cell subsets in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Expression of the B7/BB1 activation antigen and its ligand CD28 in T-cell-mediated skin diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Analysis of lymphocyte costimulation in vivo using transgenic and 'knockout' mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

CD28/CTLA-4 ligands: the gene encoding CD86 (B70/B7.2) maps to the same region as CD80 (B7/B7.1) gene in human chromosome 3q13-q23

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

A genome-wide search for human type 1 diabetes susceptibility genes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Aod1, the immunoregulatory locus controlling abrogation of tolerance in neonatal thymectomy-induced autoimmune ovarian dysgenesis, maps to mouse chromosome 16.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

Markers on distal chromosome 2q linked to insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

A cell type-specific enhancer in the human B7.1 gene regulated by NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980011-2

7 January 2021

10.1016/S0952-7915(96)80011-2

Identifiers

DOI

1 reference

29 September 2017

1 reference